• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Last Minute Entresto Conference Call Today

























They are informing us of realignments in different parts of the country where one manager will be over an account team and a few reps for a given area. Supposedly Fink, or someone up there, is having a 5:30 call with the HAS.
 




Our bad Ex. Doesn’t it suck to constantly live in fear when these calls come up though? Maybe it wasn’t today, but it will be someday and we should all prepare for when it does.
 












Valsartan recall
Novartis spokesman Eric Althoff said after the initial recall last week that products sold in the US were not affected by this recall, but the FDA's ongoing review and laboratory tests found otherwise. "The presence of of NDMA was unexpected and is thought to be related to changes in the way the active substance was manufactured," the FDA release said.
Makes you proud to work for scum!!!